- Home
- SST vs CLNN Comparison
SST vs CLNN Comparison
Compare SST & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- CLNN
- Stock Information
- Founded
- SST 2013
- CLNN 2012
- Country
- SST United States
- CLNN United States
- Employees
- SST N/A
- CLNN N/A
- Industry
- SST Diversified Commercial Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- SST Consumer Discretionary
- CLNN Health Care
- Exchange
- SST Nasdaq
- CLNN Nasdaq
- Market Cap
- SST 23.3M
- CLNN 23.1M
- IPO Year
- SST N/A
- CLNN N/A
- Fundamental
- Price
- SST $0.36
- CLNN $4.90
- Analyst Decision
- SST Strong Buy
- CLNN Strong Buy
- Analyst Count
- SST 1
- CLNN 5
- Target Price
- SST $5.00
- CLNN $40.00
- AVG Volume (30 Days)
- SST 111.2K
- CLNN 114.2K
- Earning Date
- SST 05-06-2025
- CLNN 05-07-2025
- Dividend Yield
- SST N/A
- CLNN N/A
- EPS Growth
- SST N/A
- CLNN N/A
- EPS
- SST N/A
- CLNN N/A
- Revenue
- SST $333,521,000.00
- CLNN $350,000.00
- Revenue This Year
- SST N/A
- CLNN N/A
- Revenue Next Year
- SST $6.71
- CLNN $1,667.28
- P/E Ratio
- SST N/A
- CLNN N/A
- Revenue Growth
- SST N/A
- CLNN N/A
- 52 Week Low
- SST $0.29
- CLNN $2.28
- 52 Week High
- SST $1.63
- CLNN $9.20
- Technical
- Relative Strength Index (RSI)
- SST 43.87
- CLNN 83.09
- Support Level
- SST $0.35
- CLNN $2.28
- Resistance Level
- SST $0.43
- CLNN $2.90
- Average True Range (ATR)
- SST 0.04
- CLNN 0.34
- MACD
- SST -0.01
- CLNN 0.20
- Stochastic Oscillator
- SST 14.38
- CLNN 98.13
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.